Literature DB >> 16567288

Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis.

Craig D Ainsworth1, Allan C Skanes, George J Klein, Lorne J Gula, Raymond Yee, Andrew D Krahn.   

Abstract

BACKGROUND: Ventricular tachycardia (VT) resulting from arrhythmogenic right ventricular cardiomyopathy (ARVC) may be difficult to differentiate from idiopathic right ventricular outflow tract (RVOT) VT.
OBJECTIVES: The purpose of this study was to investigate the hypothesis that QRS characteristics would be different in ARVC because of altered conduction through abnormal myocardium.
METHODS: In 24 RVOT VT patients (18 women and 6 men; age 42 +/- 10 years) and 20 ARVC patients (12 women and 8 men; age 38 +/- 14 years), mean QRS duration, frontal plane axis, and precordial R-wave transition were measured in 12-lead ECGs recorded during VT.
RESULTS: Mean QRS duration was longer in all 12 leads in ARVC patients. A significant difference was noted in leads I, III, aVL, aVF, V(1), V(2), and V(3) (P <.05). Leads I and aVL had the largest mean difference between ARVC and RVOT VT patients of 17.6 +/- 4.7 ms and 15.8 +/- 7.5 ms, respectively (P <.0001). Lead I QRS duration > or =120 ms had a sensitivity of 100%, specificity 46%, positive predictive value 61%, and negative predictive value 100% for ARVC. The area under the receiver operating characteristic (ROC) curve was 0.89. The addition of mean QRS axis <30 degrees (R<S in lead III) to the above criterion increased specificity for ARVC to 100%. QRS duration remained sensitive and specific in the subgroup of nine ARVC ECGs with an inferior axis (ROC area 0.82). R-wave transition was not different between groups.
CONCLUSION: QRS duration is longer in ARVC compared with RVOT VT. An algorithm combining lead I QRS duration for sensitivity and axis for specificity is useful for differentiating the two tachycardia substrates.

Entities:  

Mesh:

Year:  2006        PMID: 16567288     DOI: 10.1016/j.hrthm.2005.12.024

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  18 in total

1.  Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.

Authors:  Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba
Journal:  Circulation       Date:  2010-02-19       Impact factor: 29.690

Review 2.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations.

Authors:  Thomas Herren; Philipp A Gerber; Firat Duru
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

3.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: an update.

Authors:  Hugh Calkins; Frank Marcus
Journal:  Curr Cardiol Rep       Date:  2008-09       Impact factor: 2.931

4.  The challenge of diagnosing arrhythmogenic right ventricular cardiomyopathy in the young.

Authors:  Shubhayan Sanatani; Walter Duncan; Suzanne Chan
Journal:  Pediatr Cardiol       Date:  2008-04-22       Impact factor: 1.655

5.  Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.

Authors:  Frank I Marcus; William J McKenna; Duane Sherrill; Cristina Basso; Barbara Bauce; David A Bluemke; Hugh Calkins; Domenico Corrado; Moniek G P J Cox; James P Daubert; Guy Fontaine; Kathleen Gear; Richard Hauer; Andrea Nava; Michael H Picard; Nikos Protonotarios; Jeffrey E Saffitz; Danita M Yoerger Sanborn; Jonathan S Steinberg; Harikrishna Tandri; Gaetano Thiene; Jeffrey A Towbin; Adalena Tsatsopoulou; Thomas Wichter; Wojciech Zareba
Journal:  Eur Heart J       Date:  2010-02-19       Impact factor: 29.983

6.  Electrocardiographic (ECG) clues to differentiate idiopathic right ventricular outflow tract tachycardia (RVOTT) from arrhythmogenic right ventricular cardiomyopathy (ARVC).

Authors:  Zahra Emkanjoo; Reza Mollazdeh; Abolfath Alizadeh; Jalal Kheirkhah; Zarrin Mohammadi; Mazdak Khalili; Amirhossein Azhari; Sorayya Shahrzad
Journal:  Indian Heart J       Date:  2014-12-17

Review 7.  Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease.

Authors:  Ardan M Saguner; Corinna Brunckhorst; Firat Duru
Journal:  World J Cardiol       Date:  2014-04-26

Review 8.  Mechanism, diagnosis, and treatment of outflow tract tachycardia.

Authors:  Bruce B Lerman
Journal:  Nat Rev Cardiol       Date:  2015-08-18       Impact factor: 32.419

9.  Arrhythmogenic Cardiomyopathy: Electrical and Structural Phenotypes.

Authors:  Deniz Akdis; Corinna Brunckhorst; Firat Duru; Ardan M Saguner
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

10.  The use of fontaine leads in the diagnosis of arrhythmogenic right ventricular dysplasia.

Authors:  Byron Gottschalk; Michael Gysel; Raimundo Barbosa-Barros; Ricardo Paulo De Sousa Rocha; Andrés Ricardo Pérez-Riera; Li Zhang; Guy Fontaine; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-03-05       Impact factor: 1.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.